National Research Corporation (NRC) Reports Q2 EPS of $0.33
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Caribou Biosciences to halt CAR-T programs, explore sale
- Stryker names Spencer Stiles as CEO, Lobo moves to chair
- Francis Halzen wins Nobel physics prize for Antarctic 'ghost particle' hunt
National Research Corporation Announces Second Quarter 2022 Results
August 2, 2022 5:00 PM EDTLINCOLN, Neb., Aug. 02, 2022 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ: NRC) today announced results for the second quarter 2022.
Q2 2022 financial results compared to Q2 2021:
Revenue increased 2% to $37.3 millionOperating income decreased 6% to $11.5 millionIn commenting on recent events, Michael Hays, Chief Executive Officer, said, In the second quarter, our team secured the first official contract for the Human Understanding Program with Novant Health, an integrated health system serving four states... More



